EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel 8-trifluoromethylquinobenzothiazines—Synthesis and Evaluation for Antiproliferative and Antibacterial Activity

Daria Klimoszek iD, Anna Majewska iD, Małgorzata Jeleń iD, Marta Struga iD, Beata Morak-Młodawska iD, Małgorzata Dołowy iD

Pharmaceuticals · 04.03.2026 · 19 (3) · 422

DOI: 10.3390/ph19030422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 04.03.2026. Verfasst von Daria Klimoszek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Analytical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska Street 4…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia, Medical University of Silesia in Katowice.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Phenothiazine derivatives bearing trifluoromethyl substituents have attracted increasing interest as multifunctional scaffolds in drug repositioning strategies, particularly in cancer and infectious diseases. Structural modification of classical phenothiazines by incorporation of a quinoline moiety has previously been shown to enhance biological activity.

Objectives

The present study aimed to develop an efficient synthesis of 8-trifluoromethylquinobenzothiazines and to evaluate the anticancer and antibacterial potential of their N-substituted analogues inspired by triflupromazine, trifluoperazine, and fluphenazine.

Methods

6H-8-Trifluoromethylquinobenzothiazine was synthesized by cyclization of 2-amino-4-trifluoromethylbenzenethiol and 3-bromo-2-chloroquinoline. The resulting quinobenzothiazine, unsubstituted at the nitrogen atom, was subjected to N-alkylation reactions to afford eleven new 6-dialkylaminoalkyl derivatives. Structural elucidation was performed using NMR and HRMS techniques. Anticancer activity was evaluated by MTT assay against human breast (MDA-MB-231), pancreatic (Mia-PaCa-2), and lung (A-549) carcinoma cell lines, as well as normal HaCaT keratinocytes. Antibacterial activity was assessed by MIC/MBC determination against selected Gram-positive and Gram-negative reference strains and clinical isolates.

Results

Among the synthesized compounds, derivatives 8 and 12 exhibited the most favorable anticancer profiles, showing micromolar cytotoxicity (IC50 ≈ 4–10 µM) against lung and pancreatic cancer cells combined with moderate selectivity toward cancer cells over normal keratinocytes. Compound 6 displayed lower cytotoxic potency but a notably high selectivity index due to minimal toxicity toward normal cells. In antibacterial assays, compound 3 exhibited activity against Gram-positive bacteria, including a methicillin-resistant Staphylococcus aureus isolate, with MIC values ranging from 7.8 to 15.6 µg/mL. The corresponding MBC values were equal to or twofold higher than the MICs (MBC/MIC = 1–2), fulfilling commonly accepted criteria for bactericidal activity (MBC/MIC ≤ 4). OD-based growth kinetics confirmed concentration-dependent inhibition of S. aureus growth.

Conclusions

The obtained results identify 8-trifluoromethylquinobenzothiazines as a promising class of multifunctional compounds. Selected derivatives combine anticancer activity with acceptable selectivity or display potent antibacterial effects against clinically relevant Gram-positive pathogens.

Schlagwörter

Stichwörter der Autor:innen

antibacterial activityanticancer activityazaphenothiazinefluphenazinequinobenzothiazinetrifluoperazinetriflupromazine

Autor:innen und Institutionen

  • Department of Analytical Chemistry, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Jagiellońska Street 4, 41-200 Sosnowiec, Poland.
  • Chair and Department of Medical Microbiology, Medical University of Warsaw, Chalubinski 5 Street, 02-004 Warsaw, Poland.
  • Department of Organic Chemistry, Faculty of Pharmaceutical Sciences, The Medical University of Silesia, Jagiellońska 4, 41-200 Sosnowiec, Poland.
  • Chair and Department of Biochemistry, Medical University of Warsaw, 02-097 Warsaw, Poland.

ORCID-Profile: Daria Klimoszek, Anna Majewska, Małgorzata Jeleń, Marta Struga, Beata Morak-Młodawska, Małgorzata Dołowy

Förderung

  • Medical University of Silesia
  • Medical University of Silesia in Katowice

Zitieren

APA

Klimoszek, D., Majewska, A., Jeleń, M., Struga, M., Morak-Młodawska, B., & Dołowy, M. (2026). Novel 8-trifluoromethylquinobenzothiazines—Synthesis and Evaluation for Antiproliferative and Antibacterial Activity. Pharmaceuticals, 19(3), 422. https://doi.org/10.3390/ph19030422

Vancouver

Klimoszek D, Majewska A, Jeleń M, Struga M, Morak-Młodawska B, Dołowy M. Novel 8-trifluoromethylquinobenzothiazines—Synthesis and Evaluation for Antiproliferative and Antibacterial Activity. Pharmaceuticals. 2026;19(3):422. doi:10.3390/ph19030422

BibTeX
@article{Klimoszek2026,
  author = {Klimoszek, Daria and Majewska, Anna and Jeleń, Małgorzata and Struga, Marta and Morak-Młodawska, Beata and Dołowy, Małgorzata},
  title = {Novel 8-trifluoromethylquinobenzothiazines—Synthesis and Evaluation for Antiproliferative and Antibacterial Activity},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {3},
  pages = {422},
  doi = {10.3390/ph19030422}
}
Kostenlos starten →